JPRN-UMIN000025132已完成未知
The clinical pilot study to examine the distribution of [11C]K-2 in depression, bipolar disease, schizophrenia, addiction,ASD,epilepsy and FTD patients in oreder to develope the novel diagnostic method in cross-sectional way toward these diseases - The clinical trial to examine the distribution of [11C]K-2 in psychiatric patients and healthy volunteers
Yokohama City University, School of Medicine0 个研究点目标入组 110 人开始时间: 2016年12月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Subjects who undergo hemodialysis 2. Subjects who suffer from severe liver dysfunction 3. Subjects who suffer from neurological disorders except for neurodegenerative diseases and stroke 4. Subjects who have history of epilepsy (expect for 5> above) 5. Subjects who are taking Perampanel 6. Subjects who have had a history of substance abuse 7. Subjects who are positive in a urine screening test for addictive substances 8. Subjects who have used addictive substances fro the past 2 weeks (2> and 3> above) 9. Subjects who have experienced any of the following neuromodulation therapies: r-TMS, DBS, t-DCS, and MST 10. Subjects who have metals or a pacemaker inside their body 11.Subjects who have large head, neck or body so that they do not fit an MRI scanner 12.Subjects who have tattoos 13. Being claustrophobic 14. Subjects who have significant abnormalities in the brain 15. Subjects who shoe any of the following lab results - A serum creatinine level of 1.5mg/dL or higher - AST of 100IU/L or higher - ALT of 100IU/L or higher 16. Subjects who have undergone any examination with unapproved nuclear medicine in clinical trials for the past six months before this registration 17.Subjects who have participated in other clinical trials for the past 12 weeks before this registration 18. Study doctors consider their participation inappropriate In case that subjects who meet the Inclusion criteria 7) or 9), consider 19), 20) and 21) as well. 19. Subjects who have a previous history of schizophrenia, alcohol use disorder, amphetamine use disorder, gambling disorder, epilepsy, or ASD for their lifetime or major depressive episode or manic episode for one previous year. 20. Subject who suffer from neurodegenerative diseases, normal pressure hydrocephalus, or demyelinating diseases 21. A GDS score of 5 or more
研究者
相似试验
招募中
不适用
Trastuzumab (Herclon) labelled with Radioisotope for HER2 positive metastatic breast cancerCTRI/2018/09/015755Intramural Tata Memorial Centre
已完成
不适用
A Pilot study to evaluate the Clinical Application of Ultrasound ElastographyTopic: Generic Health Relevance and Cross Cutting ThemesSubtopic: Generic Health Relevance (all Subtopics)Disease: OtherSurgeryUltrasound ElastographyISRCTN45311436Cambridge University Hospitals NHS Foundation Trust (UK)600
尚未招募
2 期
A Study to find the Effectiveness of Siddha treatment for Vathakarsanam (Diabetic Peripheral Neuropathy)CTRI/2024/06/069492I
尚未招募
2 期
A Pilot Clinical study of Siddha Medicine in the treatment of Pen Maladu (Female Infertility)CTRI/2017/03/008067ational Institute of Siddha10
尚未招募
Unknown
Clinical trial to evaluate efficacy of chitramutti madakku thailam peechu therapy in the management of thandagavathsmCTRI/2023/10/058490nil